Ambulatory Surgical Centers Market to Reach USD 150.6 Billion by 2033 with 4.5% CAGR

The global ambulatory surgical centers (ASCs) market is projected to witness steady growth, with its valuation increasing from US$ 96.5 billion in 2023 to US$ 150.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of 4.5% over the forecast period. This rise is fueled by the growing demand for cost-effective and efficient alternatives to inpatient surgical procedures.

Ambulatory surgical centers (ASCs) offer a range of benefits, including improved efficiency, reduced treatment costs, and faster recovery times for patients. As a more affordable alternative to hospital-based surgical care, ASCs have gained popularity among managed care organizations, self-insured employers, and government payers seeking to reduce healthcare costs. Unlike hospitals, ASCs have significantly lower overhead, administrative, and facility maintenance costs, making them an attractive option for patients and payers alike.

The shift toward value-based healthcare models has further accelerated the adoption of ASCs. With healthcare providers focused on reducing operational costs and enhancing patient outcomes, ASCs are increasingly seen as a preferred option for outpatient surgeries and minimally invasive procedures. Advances in surgical technology and anesthesia have also facilitated the expansion of procedures that can be performed in an outpatient setting, driving further market growth.

As healthcare providers prioritize cost containment and operational efficiency, ASCs are expected to play an even greater role in the delivery of affordable and high-quality surgical care. The ongoing shift to outpatient care settings will continue to support the market's expansion, with government and private payers favoring ASCs for their ability to deliver cost-effective care without compromising quality.

Request a Sample of this Report Now:
https://www.futuremarketinsights.com/reports/sample/rep-gb-5071

Key Takeaways:

The global ambulatory surgical centers (ASCs) market is projected to grow from US$ 96.5 billion in 2023 to US$ 150.6 billion by 2033, with a CAGR of 4.5%.
Lower costs and operational efficiency make ASCs a preferred alternative to hospital-based care for managed care organizations, employers, and government payers.
The shift toward value-based healthcare and outpatient care models is driving demand for ASCs.
Advances in surgical technology and minimally invasive procedures are enabling more surgeries to be performed in ambulatory settings, supporting sustained market growth.

Market Drivers

Cost-Effectiveness: ASCs are recognized for their ability to provide surgical services at lower costs compared to traditional hospital settings, as they eliminate unnecessary services and reduce overhead costs.
Efficiency and Convenience: Designed to maximize efficiency, ASCs allow for quicker patient turnover and shorter wait times, making them an attractive option for both patients and healthcare providers.
Increasing Preference for Outpatient Care: There is a growing trend among patients and insurers to opt for outpatient surgical procedures, driven by the rising costs of hospital stays and the effectiveness of ASCs in delivering quality care.
Technological Advancements: Innovations in surgical techniques and equipment, such as minimally invasive surgeries, are enhancing the capabilities of ASCs, further driving their adoption.
Support from Managed Care Organizations: Managed care companies, self-insured employers, and government payers increasingly prefer low-cost ambulatory care services, contributing to the growth of the ASC market.

Challenges

Regulatory Compliance: Navigating regulatory requirements can be complex for ASCs, which may hinder their operational efficiency and expansion.
Competition with Hospitals: ASCs face competition from hospitals that are also expanding their outpatient services, which could impact market share.

Regional Insights

North America: Expected to dominate the ASC market due to high healthcare expenditure, advanced medical technologies, and a significant number of outpatient procedures performed annually.
Asia-Pacific: Anticipated to exhibit strong growth driven by increasing healthcare investments and a rising demand for cost-effective surgical solutions.
Prominent Companies Establishing ASCs to Expand their Reach to Patients

Leading players operating in the ambulatory surgical centers market are aiming to strengthen their market position. Strategic moves employed by key players include product approvals, collaborations, mergers, acquisitions, and partnerships with established and emerging market players.

For instance:

In January 2023, Becker's Healthcare announced that the Dallas-based Baylor Scott and White Health are planning to develop a four-story medical office building. The city's planning committee permitted the land expansion for the hospital in December 2022. The 1,00,000 sq foot structure would inhabit an ASC, gastroenterology, endocrinology, and ophthalmology departments, and more.
In 2021, Tenet Healthcare announced its plan to establish 40 ambulatory surgical centers with a total expenditure amounting to US$ 150 million. The company expects its surgery business to register a larger share, in comparison to its hospital business, over the next three years.
In January 2020, Surgery Partners acquired Vista Surgical Center which operates in ophthalmic therapeutics to provide healthcare services in the outpatient department.

List Encompassing Key Players Operating in the Ambulatory Surgical Centers Market:

AmSurg Corp
Tenet Healthcare
HCA Holdings, Inc.
Surgical Care Affiliates, Inc.
Surgery Partners
Ambulatory Surgical Centers of America
Pinnacle III
Proliance Surgeons
Regent Surgical Health
SurgCenter Development
Ambulatory Surgical Centers Market by Category

By Centers Type:

Single Specialty Centers
MultiSpecialty Centers

By Modality:

Hospital-Based Ambulatory Surgical Center
Freestanding Ambulatory Surgical Center

By Services:

Diagnostic Services
Surgical Services

By Specialty Area:

Gastroenterology
Ophthalmology
Orthopedics
Pain/Neurology
Urology
Dermatology
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan
Japan
The Middle East and Africa (MEA)

Explore FMI's Related Ongoing Coverage on Healthcare Market Insights Domain:

Bioprocess Integrity Testing Systems Market - https://www.futuremarketinsights.com/reports/bioprocess-integrity-testing-systems-market

Heat Therapy Units Market - https://www.futuremarketinsights.com/reports/heat-therapy-units-market

Adiponectin Testing Market -https://www.futuremarketinsights.com/reports/adiponectin-testing-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

This release was published on openPR.